Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$629.81M$629.81Mderived+7.1% vs Q4 2023 Net Income-$23.83M-$23.83MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$227,258,000+32.4% Operating Incomederived$37,691,000N/M Operating Cash Flowderived$40,192,000−56.0% Free Cash Flowderived$16,111,000−73.7% Margins · derivedGross margin36.1%+6.9 pt vs Q4 2023
Operating margin6.0%+8.1 pt vs Q4 2023
Net margin-3.8%−0.9 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 27, 2025 · 58 d after period end